207) Static stretching demonstrated a significant negative effect |
208) orns with hsPDA in the first week of life demonstrated a significant reduction in pl |
209) The results demonstrated a significant reduction in th |
210) 3 weeks of OTX008 treatment (5 mg/kg/day) demonstrated a significant reduction in tu |
211) clarithromycin (prophylaxis-1, rescue-1) demonstrated a significantly beneficial ro |
212) Our analysis has demonstrated a slight superiority for chlo |
213) The SEM study demonstrated a sphere-shaped and mean size |
214) This demonstrated a statistically significant r |
215) The results demonstrated a statistically significant r |
216) seminal work by Va et al., theoretically demonstrated a strong dependence of correl |
217) Previously, we demonstrated a two-layer, submicrometer-sc |
218) on compared to the only prior work, which demonstrated the GC-MRR idea for the first |
219) The results from this study demonstrated the applicability of using NM |
220) In addition, several studies have demonstrated the clinical usefulness of ca |
221) We demonstrated the conjugation of: 1) DM1 en |
222) Extensive simulation studies have demonstrated the desirable operating chara |
223) Several studies have demonstrated the diagnostic value of non-i |
224) Many studies have demonstrated the efficacy of ketamine in r |
225) In summary, these data demonstrated the expression and function o |
226) ve it for 6 days over a 2-week period and demonstrated the feasibility and safety of |
227) We demonstrated the feasibility of sMRI-aided |
228) Celecoxib demonstrated the highest rate of Brooker c |
229) The body of work demonstrated the importance of carefully d |
230) The study has also demonstrated the importance of duplicate b |
231) Results of Study I demonstrated the intelligent agent's abili |
232) The literature demonstrated the interplay between organiz |
233) Our results demonstrated the killing effects in retino |
234) A diagnostic laparotomy demonstrated the lack of a gallbladder an |
235) Naproxen demonstrated the lowest rate of Brooker I |
236) Argatroban demonstrated the lowest rate of thromboemb |
237) CLIA-RBD assay reached 96%, while LFIA-S demonstrated the lowest sensitivity, 71% ( |
238) Statistical analysis demonstrated the mass spectra similarity o |
239) Multiple studies have demonstrated the negative impact of cancer |
|